Legomics is a biotechnology company located in New York, New York, specializing in advanced genomic and molecular analysis. Situated in the heart of the city at 375 Park Avenue, Suite 2607, Legomics operates within a dynamic environment that supports innovation and scientific exploration. The company focuses on delivering cutting-edge biotechnological solutions tailored to research institutions, healthcare providers, and industry partners.
The team at Legomics applies a multidisciplinary approach to biotechnology, leveraging expertise in genetics, bioinformatics, and molecular biology. This allows the company to address complex biological questions and contribute to the development of novel diagnostic tools and therapeutic strategies. By integrating data-driven methodologies with experimental science, Legomics aims to support advancements in personalized medicine and genomic research.
Legomics is committed to maintaining a collaborative atmosphere, often working alongside academic researchers and commercial entities to accelerate the translation of scientific discoveries into practical applications. The company’s location in New York City provides access to a wide network of scientific resources and potential partnerships, enhancing its ability to stay at the forefront of biotechnology developments.
With a focus on precision and innovation, Legomics continues to build its presence within the biotechnology sector, offering specialized services and solutions that respond to evolving challenges in health and biological sciences. Interested parties can reach the company at 347-466-9213 for inquiries related to their biotechnology capabilities and projects.


































